| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |